Yongjun Li
Impact in
- Microbiology top 5%
- Infectious Diseases top 5%
- SARS-CoV-2 detection and testing
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- Metabolism, Diabetes, and Cancer 2
- Protein Kinase Regulation and GTPase Signaling 2
- Melanoma and MAPK Pathways 2
- Circular RNAs in diseases 2
-
- Cardiac Fibrosis and Remodeling 5
- Acute Myocardial Infarction Research 2
- Cardiovascular Function and Risk Factors 2
- Co-authors
- Bijie Hu (1 shared paper)Mengran Wang (1 shared paper)Wenting Jin (1 shared paper)Yingnan Huang (1 shared paper)Bing Li (1 shared paper)Chunmei Zhou (1 shared paper)Xiaoling Xu (1 shared paper)Yi Su (1 shared paper)
- Journals
- Diabetes/Metabolism Research and Reviews (2 papers)Microbial Drug Resistance (1 paper)Heart (1 paper)Journal of the American College of Cardiology (1 paper)Journal of Cardiovascular Pharmacology (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Yongjun Li
42 papers receiving 1.5k citations
Yongjun Li's Hit Papers
Peers
Comparison fields: 5 of 109
- Microbiology 22
- Infectious Diseases 267
- Epidemiology 299
- Clinical Biochemistry 62
- Microbiology 49
Countries citing papers authored by Yongjun Li
This map shows the geographic impact of Yongjun Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongjun Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongjun Li more than expected).
Fields of papers citing papers by Yongjun Li
This network shows the impact of papers produced by Yongjun Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongjun Li. The network helps show where Yongjun Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Yongjun Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Microbiological Diagnostic Performance of Metagenomic Next-generation Sequencing When Applied to Clinical Practice Hit paper breakdown → | 2018 | 630 |
| 2 | 2020 | 171 | |
| 3 | 2011 | 76 | |
| 4 | 2012 | 63 | |
| 5 | 2007 | 50 | |
| 6 | 2009 | 46 | |
| 7 | 2016 | 46 | |
| 8 | 2018 | 43 | |
| 9 | 2018 | 40 | |
| 10 | 2011 | 32 | |
| 11 | 2015 | 30 | |
| 12 | 2014 | 27 | |
| 13 | 2015 | 26 | |
| 14 | 2018 | 24 | |
| 15 | 2021 | 23 | |
| 16 | 2020 | 22 | |
| 17 | 2008 | 21 | |
| 18 | 2020 | 13 | |
| 19 | 2010 | 13 | |
| 20 | 2014 | 13 |
About Yongjun Li
Yongjun Li is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Epidemiology, Cancer Research and Infectious Diseases, having authored 43 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cardiac Fibrosis and Remodeling (5 papers), Metabolism, Diabetes, and Cancer (2 papers), Protein Kinase Regulation and GTPase Signaling (2 papers), Melanoma and MAPK Pathways (2 papers), Folate and B Vitamins Research (2 papers), Circular RNAs in diseases (2 papers), Acute Myocardial Infarction Research (2 papers) and Cardiovascular Function and Risk Factors (2 papers). The work is most often cited by research in Microbiology (22 citations), Infectious Diseases (267 citations), Epidemiology (299 citations), Clinical Biochemistry (62 citations) and Microbiology (49 citations). Yongjun Li has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Bijie Hu, Mengran Wang, Wenting Jin, Yingnan Huang, Bing Li, Chunmei Zhou, Xiaoling Xu, Yi Su, Yao Zhang and Qing Miao. Their work appears in journals such as Diabetes/Metabolism Research and Reviews, Microbial Drug Resistance, Heart, Journal of the American College of Cardiology and Journal of Cardiovascular Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.